Malignant Bone Neoplasm — Trials

Malignant Bone Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

152 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 38
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01267955	Vismodegib in Treating Patients With Advanced Chondrosarcomas	active not recruiting	Phase 2	45	National Cancer Institute (NCI)NIH	1	Aug 13, 2026	clinicaltrials
NCT04458922	Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma	active not recruiting	Phase 2	27	National Cancer Institute (NCI)NIH	2	Jul 31, 2026	clinicaltrials